Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCan-Fite BioPharma Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 0 | $0.00 | $0.00 | $0.00 |
Can-Fite BioPharma Ltd. Earnings Date And Information
Can-Fite BioPharma Ltd. last posted its earnings results on Thursday, December 26th, 2024. The company reported $-0.43 earnings per share for the quarter, missing analysts' consensus estimates of $-0.27 by $0.16. The company had revenue of 158,000 for the quarter and had revenue of 743,000 for the year. Can-Fite BioPharma Ltd. has generated $-2 earnings per share over the last year ($-1.79 diluted earnings per share) and currently has a price-to-earnings ratio of -2.27. Can-Fite BioPharma Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Can-Fite BioPharma Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2024 | Q2 2024 | N/A | -$0.00 | N/A | $300,000 | $158,000 |
| 03/28/2024 | Q1 2024 | -$0.27 | -$0.00 | 0.27 | N/A | $158,000 |
| 03/28/2024 | Q4 2023 | -$0.27 | -$0.00 | 0.27 | N/A | $155,000 |
| 11/30/2023 | Q3 2023 | -$0.43 | -$0.00 | 0.43 | $200,000 | $196,000 |
| 06/01/2023 | Q2 2023 | -$1.52 | -$0.00 | 1.52 | $200,000 | $196,000 |
| 06/01/2023 | Q1 2023 | -$1.52 | -$0.00 | 1.52 | N/A | $196,000 |
| 03/30/2023 | Q4 2022 | -$0.57 | -$0.00 | 0.57 | N/A | $197,000 |
| 11/25/2022 | Q3 2022 | -$1.00 | -$0.00 | 1 | $300,000 | $204,000 |
| 06/29/2022 | Q2 2022 | N/A | -$0.00 | N/A | $250,000 | $204,000 |
| 03/24/2022 | Q1 2022 | -$1.80 | -$0.00 | 1.8 | N/A | $205,000 |
| 11/26/2021 | Q4 2021 | -$1.00 | -$0.01 | 0.99 | N/A | $204,000 |
| 11/26/2021 | Q3 2021 | -$1.00 | -$0.01 | 0.99 | $140,000 | $251,000 |
| 06/29/2021 | Q2 2021 | N/A | -$0.01 | N/A | $218,333 | $250,000 |
| 03/25/2021 | Q1 2021 | -$1.30 | -$0.00 | 1.3 | N/A | $148,000 |
| 11/30/2020 | Q4 2020 | -$2.50 | -$0.01 | 2.49 | N/A | $150,000 |
| 11/30/2020 | Q3 2020 | -$2.50 | -$0.01 | 2.49 | $500,000 | $211,000 |
| 06/29/2020 | Q2 2020 | N/A | -$0.01 | N/A | $250,000 | $204,000 |
| 03/31/2020 | Q1 2020 | N/A | -$0.03 | N/A | N/A | $198,000 |
| 11/29/2019 | Q4 2019 | -$5.80 | -$0.04 | 5.76 | N/A | $192,000 |
| 11/29/2019 | Q3 2019 | -$5.80 | -$0.03 | 5.77 | N/A | $1.15 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Can-Fite BioPharma Ltd. Earnings: FAQ's
Can-Fite BioPharma Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based offlast year's report dates.
The conference call for Can-Fite BioPharma Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Can-Fite BioPharma Ltd.'s latest earnings report can be read online.
Can-Fite BioPharma Ltd. (:CANF) has a recorded annual revenue of $743,000.
Can-Fite BioPharma Ltd. (:CANF) has a recorded net income of $-7,634,000.Can-Fite BioPharma Ltd. has generated $-1.79 earnings per share over the last four quarters.
Can-Fite BioPharma Ltd. (:CANF) has a price-to-earnings ratio of -2.27 and price/earnings-to-growth ratio is -0.08.